Advances in Urology / 2017 / Article / Fig 1

Clinical Study

The Persistence of Silodosin Monotherapy and the Reasons for Withdrawal from Treatment of Previously Untreated Japanese Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia

Figure 1

Kaplan-Meier plots of the persistence rates of silodosin treatment for 4 years of follow-up. The 6-month, 1-year, 2-year, 3-year, and 4-year persistence rates were 63.0%, 56.8%, 50.6%, 44.4%, and 35.8%, respectively.